CEO and co-founder of Curavit. Prior to founding Curavit at the end of 2019 I was CEO and co-founder of C3i. C3i provided global clinical solutions to the top 100 Pharma, CROs, and clinical software companies. C3i was sold to Merck in 2014 and Joel stayed on at Merck continuing to run this business as well as other Merck owned businesses.
